GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » Gross-Profit-to-Asset %

Bionoid Pharma (Bionoid Pharma) Gross-Profit-to-Asset % : -39.66% (As of Mar. 2011)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bionoid Pharma's annualized Gross Profit for the quarter that ended in Mar. 2011 was $-0.39 Mil. Bionoid Pharma's average Total Assets over the quarter that ended in Mar. 2011 was $0.99 Mil. Therefore, Bionoid Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2011 was -39.66%.


Bionoid Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Bionoid Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma Gross-Profit-to-Asset % Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Gross-Profit-to-Asset %
- - - -41.74 -27.97

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.94 -67.78 -66.90 -21.91 -39.66

Competitive Comparison of Bionoid Pharma's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionoid Pharma's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's Gross-Profit-to-Asset % falls into.



Bionoid Pharma Gross-Profit-to-Asset % Calculation

Bionoid Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2010 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2010 )/( (Total Assets (A: Dec. 2009 )+Total Assets (A: Dec. 2010 ))/ count )
=-0.252/( (0.472+1.33)/ 2 )
=-0.252/0.901
=-27.97 %

Bionoid Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2011 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2011 )/( (Total Assets (Q: Dec. 2010 )+Total Assets (Q: Mar. 2011 ))/ count )
=-0.392/( (1.33+0.647)/ 2 )
=-0.392/0.9885
=-39.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2011) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bionoid Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionoid Pharma (Bionoid Pharma) Business Description

Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.